Literature DB >> 2487150

Secondary nonrandom chromosomal abnormalities of band 13q34 in Burkitt lymphoma-leukemia.

R Berger1, M Le Coniat, J Derré, D Vecchione.   

Abstract

Clonal abnormalities of the long arm of chromosome 13 were detected in 9 of 54 patients with Burkitt lymphoma-leukemia. All abnormalities involved band 13q34, in three patients as t(1;13). The 13q34 abnormalities are thus the second most frequent secondary chromosomal abnormalities, after those of chromosome I, in these lymphoid proliferations.

Entities:  

Mesh：

Year:  1989        PMID： 2487150     DOI： 10.1002/gcc.2870010202

Source DB:  PubMed          Journal:  Genes Chromosomes Cancer        ISSN： 1045-2257            Impact factor:   5.006


  6 in total

1.  Molecular cloning and expression of human cDNAs encoding a novel DNA ligase IV and DNA ligase III, an enzyme active in DNA repair and recombination.

Authors:  Y F Wei; P Robins; K Carter; K Caldecott; D J Pappin; G L Yu; R P Wang; B K Shell; R A Nash; P Schär
Journal:  Mol Cell Biol       Date:  1995-06       Impact factor: 4.272

2.  An increased frequency of 13q deletions detected by fluorescence in situ hybridization and its impact on survival in children and adolescents with Burkitt lymphoma: results from the Children's Oncology Group study CCG-5961.

Authors:  Marilu Nelson; Sherrie L Perkins; Bhavana J Dave; Peter F Coccia; Julia A Bridge; Elizabeth R Lyden; Nyla A Heerema; Mark A Lones; Lauren Harrison; Mitchell S Cairo; Warren G Sanger
Journal:  Br J Haematol       Date:  2009-11-04       Impact factor: 6.998

Review 3.  Actions of BAFF in B cell maturation and its effects on the development of autoimmune disease.

Authors:  F Melchers
Journal:  Ann Rheum Dis       Date:  2003-11       Impact factor: 19.103

4.  The biology of HIV-associated lymphomas.

Authors:  M Bower
Journal:  Br J Cancer       Date:  1992-09       Impact factor: 7.640

5.  BAFF, a novel ligand of the tumor necrosis factor family, stimulates B cell growth.

Authors:  P Schneider; F MacKay; V Steiner; K Hofmann; J L Bodmer; N Holler; C Ambrose; P Lawton; S Bixler; H Acha-Orbea; D Valmori; P Romero; C Werner-Favre; R H Zubler; J L Browning; J Tschopp
Journal:  J Exp Med       Date:  1999-06-07       Impact factor: 14.307

6.  Specific cytogenetic abnormalities are associated with a significantly inferior outcome in children and adolescents with mature B-cell non-Hodgkin's lymphoma: results of the FAB/LMB 96 international study.

Authors:  H A Poirel; M S Cairo; N A Heerema; J Swansbury; A Aupérin; E Launay; W G Sanger; P Talley; S L Perkins; M Raphaël; K McCarthy; R Sposto; M Gerrard; A Bernheim; C Patte
Journal:  Leukemia       Date:  2008-11-20       Impact factor: 11.528
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.